Viking Therapeutics: The Prime Target In The Obesity Gold Rush

Group 1 - Viking Therapeutics, Inc. (NASDAQ: VKTX) is identified as a potential investment opportunity in the pharmaceutical sector, which is currently experiencing a downturn [1] - The focus is on undervalued and disliked companies with strong fundamentals and good cash flows, particularly in sectors like Oil & Gas and consumer goods [1] - The investment strategy emphasizes long-term value investing while also considering deal arbitrage opportunities, such as notable mergers and acquisitions [1] Group 2 - The article aims to connect with like-minded investors through Seeking Alpha, fostering a collaborative community focused on superior returns and informed decision-making [1]